Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tikvah Therapeutics logo — Pioneering advancements in neurology and psychiatry to meet...

Tikvah Therapeutics

Pioneering advancements in neurology and psychiatry to meet critical needs in the central nervous system.

Founded 2005 Series Unknown Total: $10.00M

General Information

Company Name Tikvah Therapeutics
Founded Year 2005
Funding Stage Series Unknown
Social

Get notified when Tikvah Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tikvah Therapeutics

Tikvah Therapeutics is a company that is pioneering advancements in neurology and psychiatry to meet critical needs in the central nervous system. The company was founded in 2005 and focuses on acquiring, developing, and commercializing novel therapeutics addressing significant unmet medical needs related to neurology and psychiatry. The latest investment in Tikvah Therapeutics was a $10.00M Venture Round investment on 14 July 2007. However, the specific details about the investors and headquarters are not provided. Tikvah Therapeutics' dedication to addressing unmet medical needs in the central nervous system positions the company as an intriguing opportunity for potential investors looking to support advancements in neurology and psychiatry.

Taxonomy: neurology, psychiatry, central nervous system, therapeutics, medical needs, unmet needs, acquisitions, development, commercialization

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 14 Jul 2007

Tikvah Therapeutics Alternatives & Competitors

Tikvah Therapeutics vs
Handl Therapeutics
Handl Therapeutics Belgium

Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through academic a...

Grant
Biotechnology, Health Care
Tikvah Therapeutics vs
Amberstone Biosciences
Amberstone Biosciences United States

Developing Next-generation Tumor Microenvironment Activated Therapeutics

Series A
13 employees
Biotechnology, Health Care
Tikvah Therapeutics vs
PROSION
PROSION

Addressing unmet medical needs through innovation in drug development

Seed
2-10 employees
Pharmaceutical

FAQ About Tikvah Therapeutics

Pioneering advancements in neurology and psychiatry to meet critical needs in the central nervous system.
Tikvah Therapeutics was founded in 2005.
Tikvah Therapeutics has completed 1 funding round, raising a total of $10.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Tikvah Therapeutics include Handl Therapeutics, Amberstone Biosciences, PROSION, Pinteon Therapeutics, VeonGen Therapeutics GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tikvah Therapeutics and Handl Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tikvah Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy